Literature DB >> 27572517

Cardioprotective potential of a lanosteryl triterpene from Protorhus longifolia.

Rebamang A Mosa1, Nomadlozi B Hlophe1, Namani T Ngema1, Dambudzo Penduka1, Oladipupo A Lawal2, Andy R Opoku1.   

Abstract

CONTEXT: The current rapid increase in the incidence of cardiovascular events indicates a need for the discovery of more effective cardioprotective agents.
OBJECTIVE: This study evaluated the cardioprotective potential of a lanosteryl triterpene from Protorhus longifolia (Benrh.) Engl. stem bark.
MATERIALS AND METHODS: Spectroscopic data analysis was used to confirm the structure of methyl-3β-hydroxylanosta-9, 24-dien-21-oate (RA-3). The cardioprotective effect of RA-3 in isoproterenol-induced myocardial injury in hyperlipidemic rats was investigated. Rats were divided into the normal diet (ND) fed and high fat diet (HFD) fed groups. The HFD rats were further subdivided into three groups. The experimental group was orally administered with RA-3 (100 mg/kg) for 15 days. The rats were then injected with isoproterenol (85 mg/kg) to induce myocardial injury. At the end of the experiment, hearts and blood tissues were collected and used for histology and biochemical assays, respectively.
RESULTS: RA-3 exhibited a cardioprotective effect as it minimized myocardial injury in HFD rats. Few lesions of acute hyaline degeneration and reduced fat deposition were observed in the heart tissue of the triterpene pretreated rats. Lactate dehydrogenase (LDH) activity was decreased in the blood of the RA-3 pretreated rats (44.1 mU/mL) compared to the untreated group (64.8 mU/mL). Increased glutathione (GSH) content and catalase (CAT) activity along with lower levels of malondialdehyde (MDA) in the triterpene pretreated animals (120.8 nmol/μL) than in the non-treated HFD fed rats (143.6 nmol/μL) were also observed. DISCUSSION AND
CONCLUSION: The cardioprotective effect exhibited by RA-3 indicates its potential use in the management of cardiovascular diseases (CVD) and related health problems.

Entities:  

Keywords:  Cardioprotective effect; antioxidant; hyperlipidemia

Mesh:

Substances:

Year:  2016        PMID: 27572517     DOI: 10.1080/13880209.2016.1223144

Source DB:  PubMed          Journal:  Pharm Biol        ISSN: 1388-0209            Impact factor:   3.503


  4 in total

Review 1.  Lanosteryl triterpenes from Protorhus longifolia as a cardioprotective agent: a mini review.

Authors:  Nonhlakanipho F Sangweni; Phiwayinkosi V Dludla; Rebamang A Mosa; Abidemi P Kappo; Andy Opoku; Christo J F Muller; Rabia Johnson
Journal:  Heart Fail Rev       Date:  2019-01       Impact factor: 4.214

2.  A Lanosteryl Triterpene from Protorhus longifolia Improves Glucose Tolerance and Pancreatic Beta Cell Ultrastructure in Type 2 Diabetic Rats.

Authors:  Sihle E Mabhida; Rebamang A Mosa; Dambudzo Penduka; Foluso O Osunsanmi; Phiwayinkosi V Dludla; Tryana G Djarova; Andy R Opoku
Journal:  Molecules       Date:  2017-07-26       Impact factor: 4.411

3.  Molecular basis of the anti-hyperglycemic activity of RA-3 in hyperlipidemic and streptozotocin-induced type 2 diabetes in rats.

Authors:  Sihle Ephraim Mabhida; Rabia Johnson; Musawenkosi Ndlovu; Johan Louw; Andrew Opoku; Rebamang Anthony Mosa
Journal:  Diabetol Metab Syndr       Date:  2019-03-29       Impact factor: 3.320

4.  A Lanosteryl Triterpene (RA-3) Exhibits Antihyperuricemic and Nephroprotective Effects in Rats.

Authors:  Nomadlozi Blessings Hlophe; Andrew Rowland Opoku; Foluso Oluwagbemiga Osunsanmi; Trayana Georgieva Djarova-Daniels; Oladipupo Adejumobi Lawal; Rebamang Anthony Mosa
Journal:  Molecules       Date:  2020-09-02       Impact factor: 4.411

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.